Coleman Glenn bought 10 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. at $297.43 for $2.97k on Sep 30, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
EVP & Chief Financial Officer
EVP & Chief Financial Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$2,974.30Shares × reported price
Shares traded
10Common Stock
Price per share
$297.43Reported price. Read footnotes for ranges.
% of reported position traded
0.04%This security and ownership context
Holdings after
27,762Direct
Trade date
Sep 30, 2026Buy
Filed
Oct 2, 2026, 4:27 PM ET2-day reporting delay
Accession
0001100682-26-000144Code P · Transaction 234798
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 27,752 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CRL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CRL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.7%1w ago −4.4%1d ago +2%
Returns since7d +4%30d +24%90d180d1y

Footnotes in full

F1: The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period.